Demographics, treatment patterns and clinical outcomes in ROS1-positive non-small cell lung cancer: A referral tertiary cancer centre experience from a low-middle income country

被引：0
|
作者：
Panda, G. S. [1 ]
Noronha, V. [1 ]
Patil, V. M. [1 ]
Joshi, A. P. [1 ]
Menon, N. S. [1 ]
Singh, A. C. [1 ]
Kumar, R. [2 ]
Pai, T. [2 ]
Shetty, O. [2 ]
Janu, A. [3 ]
Chakrabarty, N. [3 ]
Purandare, N. [4 ]
Dey, S. [1 ]
Prabhash, K. [1 ]
机构：
[1] Tata Mem Hosp, Tata Mem Ctr, Med Oncol, Mumbai, Maharashtra, India
[2] Tata Mem Hosp, Tata Mem Ctr, Pathol, Mumbai, Maharashtra, India
[3] Tata Mem Hosp, Tata Mem Ctr, Radiol, Mumbai, Maharashtra, India
[4] Tata Mem Hosp, Tata Mem Ctr, Bioimaging, Mumbai, Maharashtra, India
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.10.428
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
391P
引用
收藏
页码：S1594 / S1595
页数：2
相关论文
共 50 条
  • [21] Patterns of Metastatic Spread and Mechanisms of Resistance to Crizotinib in ROS1-Positive Non-Small-Cell Lung Cancer
    Gainor, Justin F.
    Tseng, Diane
    Yoda, Satoshi
    Dagogo-Jack, Ibiayi
    Friboulet, Luc
    Lin, Jessica J.
    Hubbeling, Harper G.
    Dardaei, Leila
    Farago, Anna F.
    Schultz, Katherine R.
    Ferris, Lorin A.
    Piotrowska, Zofia
    Hardwick, James
    Huang, Donghui
    Mino-Kenudson, Mari
    Iafrate, A. John
    Hata, Aaron N.
    Yeap, Beow Y.
    Shaw, Alice T.
    JCO PRECISION ONCOLOGY, 2017, 1
  • [22] Preliminary efficacy and safety of lorlatinib in patients (Pts) with ROS1-positive non-small cell lung cancer (NSCLC)
    Besse, B.
    Shaw, A. T.
    Solomon, B. J.
    Bauer, T. M.
    Chiari, R.
    Lin, C-C.
    Satouchi, M.
    Clancy, J. S.
    James, L. P.
    Abbattista, A.
    Felip Font, E.
    ANNALS OF ONCOLOGY, 2017, 28
  • [23] Safety and efficacy of WX-0593 in ALK-positive or ROS1-positive non-small cell lung cancer
    Shi, Y-K.
    Fang, J.
    Zhang, S.
    Liu, Y.
    Wang, L.
    Si, M.
    Ge, M.
    Geng, H.
    ANNALS OF ONCOLOGY, 2019, 30
  • [24] Impact of lorlatinib on patient-reported outcomes in patients with advanced ALK-positive or ROS1-positive non-small cell lung cancer
    Peters, Solange
    Shaw, Alice T.
    Besse, Benjamin
    Felip, Enriqueta
    Solomon, Benjamin J.
    Soo, Ross A.
    Bearz, Alessandra
    Gadgeel, Shirish M.
    Lin, Chia-Chi
    Kao, Steven
    Seto, Takashi
    Masters, Elizabeth T.
    Abbattista, Antonello
    Clancy, Jill S.
    Thurm, Holger
    Reisman, Arlene
    Peltz, Gerson
    Camidge, D. Ross
    LUNG CANCER, 2020, 144 : 10 - 19
  • [25] FDA Approval Summary: Repotrectinib for Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer
    Barbato, Michael I.
    Bradford, Diana
    Ren, Yi
    Aungst, Stephanie L.
    Miller, Claudia P.
    Pan, Lili
    Zirkelbach, Jeanne F.
    Li, Yangbing
    Bi, Youwei
    Fan, Jianghong
    Grimstein, Manuela
    Dorff, Sarah E.
    Amatya, Anup K.
    Mishra-Kalyani, Pallavi S.
    Scepura, Barbara
    Schotland, Peter
    Udoka, Opeyemi
    Ojofeitimi, Idara
    Leighton, John K.
    Rahman, Nam A.
    Pazdur, Richard
    Singh, Harpreet
    Kluetz, Paul G.
    Drezner, Nicole
    CLINICAL CANCER RESEARCH, 2024, 30 (16) : 3364 - 3370
  • [26] Differential crizotinib efficacy among ROS1 fusion partners in ROS1-positive non-small cell lung cancer.
    Lu, Shun
    Li, Ziming
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [27] Entrectinib in ROS1-positive advanced non-small cell lung cancer: the phase 2/3 BFAST trial
    Peters, Solange
    Gadgeel, Shirish M.
    Mok, Tony
    Nadal, Ernest
    Kilickap, Saadettin
    Swalduz, Aurelie
    Cadranel, Jacques
    Sugawara, Shunichi
    Chiu, Chao-Hua
    Yu, Chong-Jen
    Moskovitz, Mor
    Tanaka, Tomohiro
    Nersesian, Rhea
    Shagan, Sarah M.
    Maclennan, Margaret
    Mathisen, Michael
    Bhagawati-Prasad, Vijay
    Diarra, Cheick
    Assaf, Zoe June
    Archer, Venice
    Dziadziuszko, Rafal
    NATURE MEDICINE, 2024, 30 (07) : 1923 - 1932
  • [28] Should Crizotinib Take It All in ROS1-Positive Non-Small-Cell Lung Cancer?
    Zeng, Liang
    Yang, Nong
    Zhang, Yongchang
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (31) : 3176 - +
  • [29] Infant Neuroblastoma: 10 Year Experience from a Tertiary Cancer Centre in a Low and Middle Income Country
    Prasanth, V. R.
    Priyakumari, T.
    Manjusha, N.
    Binitha, R.
    Guruprasad, C. S.
    Shwetha, S.
    Sindhu, N.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S274 - S274
  • [30] Analysis of Receptor Tyrosine Kinase ROS1-Positive Tumors in Non-Small Cell Lung Cancer: Identification of a FIG-ROS1 Fusion
    Rimkunas, Victoria M.
    Crosby, Katherine E.
    Li, Daiqiang
    Hu, Yerong
    Kelly, Meghan E.
    Gu, Ting-Lei
    Mack, Jennifer S.
    Silver, Matthew R.
    Zhou, Xinmin
    Haack, Herbert
    CLINICAL CANCER RESEARCH, 2012, 18 (16) : 4449 - 4457
12345